APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.

APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.

Item
http://www.wikidata.org/entity/Q41010043
The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and DiseasesProtective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical EvidenceEFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review.Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease.Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
P2860

APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.

Item
http://www.wikidata.org/entity/Q41010043
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.
@en
type
label
APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.
@en
prefLabel
APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.
@en
P1433
P1476
P2093
P2860
P31
P356
P577
P698
P932
P356
P1433
P1476
APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.
@en
P2093
P2860
P31
P356
P577
P698
P932